{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:12Z","timestamp":1787010132455,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rational:<\/jats:title>\n                    <jats:p>Multicentric Castleman disease (MCD) is a nonclonal lymphoproliferative disorder that is rarely reported from Southeast Asian countries. Here, we report a case of human herpesvirus 8 (HHV-8)-associated MCD in a patient with advanced human immunodeficiency virus (HIV) infection who presented with prolonged intermittent fever, urticarial rash, hepatosplenomegaly, and generalized lymphadenopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 34-year-old man with advanced HIV infection who was in good compliance with his antiretroviral treatment regimen presented with intermittent fever, weight loss, marked hepatosplenomegaly, and generalized lymphadenopathy. Recurrent symptoms of high-grade fever, abdominal discomfort, pancytopenia, and high C-reactive protein level occurred for 16\u200amonths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Histopathological findings of left inguinal lymph node revealed diffuse effacement of lymph node architecture with coexpression of HHV-8 latency-associated nuclear antigen 1 from immunohistochemical staining. The HHV-8 viral load was 335,391\u200acopies\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      The patient was treated initially with one dose of intravenous rituximab (375\u200amg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) followed by subcutaneous rituximab (1400\u200amg) weekly for 5\u200aweeks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient's recurrent systemic symptoms subsided dramatically, and he has now been in remission for almost two years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>HHV8-associated MCD remains a diagnostic challenge in advanced HIV disease and should be suspected in those with recurrent flares of systemic inflammatory symptoms. Lymph node histopathology is essential for diagnosis and for excluding clonal malignancy. HHV-8 viral load is also useful for diagnosis and for monitoring disease activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000028077","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T08:10:18Z","timestamp":1639123818000},"page":"e28077","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection"],"prefix":"10.1097","volume":"100","author":[{"given":"Theerajet","family":"Guayboon","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Chinthammitr","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanya","family":"Sukpanichnant","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Horthongkham","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasikarn","family":"Angkasekwinai","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273 patients studied over 20\u200ayears","volume":"180","author":"Oksenhendler","year":"2018","journal-title":"Br J Haematol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler","year":"1996","journal-title":"Aids"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1200\/JCO.2010.34.1909","article-title":"Clinical features and outcome in HIV-associated multicentric Castleman's disease","volume":"29","author":"Bower","year":"2011","journal-title":"J Clin Oncol"},{"key":"R6-20250504","first-page":"25","article-title":"Multicentric Castleman's disease in HIV infection: a systematic review of the literature","volume":"10","author":"Mylona","year":"2008","journal-title":"AIDS Rev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/hiv.12273","article-title":"The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients","volume":"17","author":"Haq","year":"2016","journal-title":"HIV Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02841860410002752","article-title":"Fifty years of multicentric Castleman's disease","volume":"43","author":"Waterston","year":"2004","journal-title":"Acta Oncol"},{"key":"R9-20250504","first-page":"28","article-title":"Multicentric Castleman's disease and HIV","volume":"27","author":"Krause","year":"2014","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R10-20250504","first-page":"4536157","article-title":"HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIV-positive patient","volume":"2019","author":"Guerrero","year":"2019","journal-title":"Case Rep Hematol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CMR.15.3.439-464.2002","article-title":"Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases","volume":"15","author":"Ablashi","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ajh.21137","article-title":"HIV-associated multicentric Castleman's disease","volume":"83","author":"Stebbing","year":"2008","journal-title":"Am J Hematol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1182\/blood.V122.21.5127.5127","article-title":"Polynesian variant of idiopathic multicentric Castleman disease","volume":"122","author":"Zhai","year":"2013","journal-title":"Blood"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3109\/10428194.2014.953145","article-title":"Use of a claims database to characterize and estimate the incidence rate for Castleman disease","volume":"56","author":"Munshi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e926433","DOI":"10.12659\/AJCR.926433","article-title":"A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-IRIS) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review","volume":"21","author":"Dumic","year":"2020","journal-title":"Am J Case Rep"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00432-020-03494-2","article-title":"Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases","volume":"147","author":"Sun","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood.V108.11.3858.3858","article-title":"Autoimmune hemolytic anemia in HIV: a case series and review of the literature","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2340\/00015555-3253","article-title":"Cutaneous disorders associated with Castleman's disease","volume":"99","author":"Kim","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1086\/521625","article-title":"Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease","volume":"196","author":"Marcelin","year":"2007","journal-title":"J Infect Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","article-title":"Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"122","author":"Polizzotto","year":"2013","journal-title":"Blood"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2011-08-376012","article-title":"Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease","volume":"119","author":"Gerard","year":"2012","journal-title":"Blood"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2016-10-747477","article-title":"Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients","volume":"129","author":"Pria","year":"2017","journal-title":"Blood"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3111\/13696998.2014.914033","article-title":"Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom","volume":"17","author":"Rule","year":"2014","journal-title":"J Med Econ"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2352-3026(17)30078-9","article-title":"Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial","volume":"4","author":"Davies","year":"2017","journal-title":"Lancet Haematol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3324\/haematol.2017.173583","article-title":"Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study","volume":"102","author":"Lugtenburg","year":"2017","journal-title":"Haematologica"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1182\/blood-2014-07-586800","article-title":"Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease","volume":"124","author":"Uldrick","year":"2014","journal-title":"Blood"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood.V98.12.3473","article-title":"Long-term remission of Kaposi sarcoma\u2013associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy","volume":"98","author":"Corbellino","year":"2001","journal-title":"Blood"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/517111","article-title":"Successful treatment of multicentric Castleman's disease in a patient with human immunodeficiency virus infection","volume":"26","author":"Revuelta","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jmv.10500","article-title":"Multicentric Castleman's disease treated with antivirals and immunosuppressants","volume":"71","author":"Senanayake","year":"2003","journal-title":"J Med Virol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:09:15Z","timestamp":1746320955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028077"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":32,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028077","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"2021-10-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}